NASDAQ:ATRI - Atrion Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$630.00 -1.35 (-0.21 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$630.00
Today's Range$628.5750 - $632.00
52-Week Range$516.85 - $694.00
Volume4,417 shs
Average Volume6,420 shs
Market Capitalization$1.17 billion
P/E Ratio33.39
Dividend Yield0.76%
Beta0.62
Atrion logoAtrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Debt-to-Equity RatioN/A
Current Ratio9.62
Quick Ratio6.95

Price-To-Earnings

Trailing P/E Ratio33.39
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$146.60 million
Price / Sales7.95
Cash Flow$23.1703 per share
Price / Cash27.19
Book Value$99.57 per share
Price / Book6.33

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$36.59 million
Net Margins23.82%
Return on Equity19.34%
Return on Assets17.32%

Miscellaneous

Employees528
Outstanding Shares1,850,000
Market Cap$1,169.16

Atrion (NASDAQ:ATRI) Frequently Asked Questions

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Tuesday, May 22nd. Stockholders of record on Friday, June 15th will be given a dividend of $1.20 per share on Friday, June 29th. This represents a $4.80 annualized dividend and a dividend yield of 0.76%. The ex-dividend date is Thursday, June 14th. View Atrion's Dividend History.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings results on Wednesday, May, 9th. The medical instruments supplier reported $4.56 EPS for the quarter. The medical instruments supplier earned $39.40 million during the quarter. Atrion had a return on equity of 19.34% and a net margin of 23.82%. View Atrion's Earnings History.

When is Atrion's next earnings date?

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Atrion.

What is the consensus analysts' recommendation for Atrion?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Atrion in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of Atrion's key competitors?

Who are Atrion's key executives?

Atrion's management team includes the folowing people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 80)
  • Mr. David A. Battat, Pres & CEO (Age 48)
  • Mr. Jeffery Strickland, VP, CFO, Sec. & Treasurer (Age 59)

Has Atrion been receiving favorable news coverage?

News headlines about ATRI stock have been trending positive this week, Accern Sentiment reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Atrion earned a coverage optimism score of 0.39 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 49.35 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Atrion's major shareholders?

Atrion's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Pennsylvania Trust Co (0.58%), Denali Advisors LLC (0.12%), Hudson Valley Investment Advisors Inc. ADV (0.05%) and Bank of Montreal Can (0.03%). Company insiders that own Atrion stock include Emile A Battat, Hugh J Morgan Jr, Jeffery Strickland and Roger F Stebbing. View Institutional Ownership Trends for Atrion.

Which institutional investors are buying Atrion stock?

ATRI stock was acquired by a variety of institutional investors in the last quarter, including Denali Advisors LLC, Hudson Valley Investment Advisors Inc. ADV, Bank of Montreal Can and Pennsylvania Trust Co. View Insider Buying and Selling for Atrion.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $630.00.

How big of a company is Atrion?

Atrion has a market capitalization of $1.17 billion and generates $146.60 million in revenue each year. Atrion employs 528 workers across the globe.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]


MarketBeat Community Rating for Atrion (NASDAQ ATRI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.